|
KIAA1191 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.720800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.910400E-01 |
| Normal-vs-Stage2 |
5.950800E-01 |
| Normal-vs-Stage3 |
7.842100E-02 |
| Normal-vs-Stage4 |
1.440420E-01 |
| Stage1-vs-Stage2 |
5.611800E-01 |
| Stage1-vs-Stage3 |
2.623500E-02 |
| Stage1-vs-Stage4 |
8.730400E-02 |
| Stage2-vs-Stage3 |
2.970200E-02 |
| Stage2-vs-Stage4 |
6.574100E-02 |
| Stage3-vs-Stage4 |
7.906800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.512400E-01 |
| Normal-vs-AfricanAmerican |
1.623390E-01 |
| Normal-vs-Asian |
7.848800E-01 |
| Caucasian-vs-AfricanAmerican |
5.475900E-02 |
| Caucasian-vs-Asian |
4.805400E-01 |
| AfricanAmerican-vs-Asian |
1.356650E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.166800E-01 |
| Normal-vs-Female |
5.998400E-01 |
| Male-vs-Female |
9.409400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.204000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.206000E-01 |
| Normal-vs-Age(61-80Yrs) |
6.426400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.655600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.079600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.665400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.872000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.344800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.939000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.534200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.863100E-03 |
| Classical-VS-Follicular |
4.500300E-02 |
| Classical-VS-Other |
8.363000E-01 |
| Classical-VS-Normal |
5.974600E-01 |
| Tall-VS-Follicular |
3.185700E-04 |
| Tall-VS-Other |
1.168600E-01 |
| Tall-VS-Normal |
1.494050E-02 |
| Follicular-VS-Other |
6.373200E-01 |
| Follicular-VS-Normal |
1.974390E-01 |
| Other-VS-Normal |
9.734200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.353800E-01 |
| Normal-vs-N1 |
5.559600E-02 |
| N0-vs-N1 |
5.179500E-02 |
|
|
